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Abstract
The efficiency of translation termination depends on the nature of the stop codon and the surrounding nucleotides. Some
molecules, such as aminoglycoside antibiotics (gentamicin), decrease termination efficiency and are currently being
evaluated for diseases caused by premature termination codons. However, the readthrough response to treatment is highly
variable and little is known about the rules governing readthrough level and response to aminoglycosides. In this study, we
carried out in-depth statistical analysis on a very large set of nonsense mutations to decipher the elements of nucleotide
context responsible for modulating readthrough levels and gentamicin response. We quantified readthrough for 66
sequences containing a stop codon, in the presence and absence of gentamicin, in cultured mammalian cells. We
demonstrated that the efficiency of readthrough after treatment is determined by the complex interplay between the stop
codon and a larger sequence context. There was a strong positive correlation between basal and induced readthrough
levels, and a weak negative correlation between basal readthrough level and gentamicin response (i.e. the factor of increase
from basal to induced readthrough levels). The identity of the stop codon did not affect the response to gentamicin
treatment. In agreement with a previous report, we confirm that the presence of a cytosine in +4 position promotes higher
basal and gentamicin-induced readthrough than other nucleotides. We highlight for the first time that the presence of a
uracil residue immediately upstream from the stop codon is a major determinant of the response to gentamicin. Moreover,
this effect was mediated by the nucleotide itself, rather than by the amino-acid or tRNA corresponding to the 21 codon.
Finally, we point out that a uracil at this position associated with a cytosine at +4 results in an optimal gentamicin-induced
readthrough, which is the therapeutically relevant variable.
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Introduction
Translation is terminated by a stop codon entering the A site of
the ribosome, inducing the release of the polypeptide chain from
the peptidyl-t-RNA [1]. Two polypeptide chain release factors
have been identified in eukaryotes: eRF1 (eukaryotic Release
Factor one), which recognizes all three nonsense codons, and
eRF3 (eukaryotic Release Factor three) which stimulates polypep-
tide release from the ribosome in a GTP and eRF1-dependent
manner [2]. Under normal conditions, translation termination at
natural termination codons is a very efficient process, with an
estimated error rate of 0.01 to 0.1% in mammalian cells
(unpublished data). However, near-cognate aminoacyl-tRNAs
(with pairing of two of the three bases) can compete with eRF1
for stop codon binding, resulting in translational readthrough. The
rules governing readthrough efficiency are far from clear, but
readthrough levels have been shown to depend on the type of stop
codon, with UAA being a better terminator than UAG and UGA,
and even more strongly on the surrounding nucleotide context [3–
6]. The effect of nucleotide context on readthrough level has been
extensively studied in yeast: Bonetti and coworkers demonstrated
that upstream and downstream components act in synergy to
determine readthrough efficiency [7]. Two studies based on the
screening of a degenerate oligonucleotide library established a
consensus sequence, NAA STOP CA (A/G) N (U/C/G) A,
promoting high levels of readthrough [6,8]. Less is currently
known about the effect of sequence context on readthrough levels
in mammalians cells, because only a small number of contexts
surrounding stop codons have been investigated.
Readthrough can be stimulated by aminoglycoside antibiotics,
such as gentamicin, making it possible to generate a full-length
protein from genes carrying a nonsense mutation [9,10]. These
antibiotics interact with the highly conserved decoding center of
ribosomal RNA, promoting the recognition of the stop codon by
a near-cognate tRNA [11,12]. A number of studies and clinical
trials have investigated the possible use of this antibiotic for the
treatment of human diseases resulting from the presence of a
premature termination codon (PTC) in a particular gene (for
review, see [13,14]). However, basal and induced readthrough
efficiencies differ considerably between nonsense mutations
[3,15] so only a subset of patients would be likely to benefit
from gentamicin treatment. Moreover, due to the complexity of
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efficiency from the nucleotide context of the nonsense mutation.
It is crucial to determine the patients most likely to benefit from
treatment, and it is currently necessary to measure the read-
through level of each nonsense mutation in cell culture, as
readthrough levels in culture are correlated with those in vivo [16].
Many studies have indicated that the nucleotide immediately
downstream from the stop codon (defined as +4) is a crucial
determinant of termination efficiency in eukaryotes [17].
Moreover, this nucleotide has been shown to crosslink with
release factor class I [18]. A cytosine (C) residue in the +4p o s i t i o n
generally promotes higher levels of readthrough in the presence
or absence of aminoglycosides. However, some nonsense
mutations with a C residue in the +4 position may display
moderate levels of readthrough [3]. Thus, the identity of the
nucleotide immediately downstream from the stop codon is not
sufficient to predict readthrough efficiency for a given nonsense
mutation. No systematic study has been performed and our
knowledge of the effects of nucleotide context on readthrough
level and gentamicin response (i.e. the factor of increase between
basal readthrough and drug-induced readthrough) is therefore
incomplete.
We used a set of 66 sequences, each containing a stop codon -
mostly nonsense mutations implicated in various human diseases
- inserted into the same reporter vector for an extensive statistical
analysis of the determinants of readthrough levels and gentamicin
response. We found a strong correlation between basal read-
through level and antibiotic-induced readthrough level and a very
weak negative correlation between basal readthrough level and
gentamicin response. The nature of the stop codon did not affect
the sensitivity of the nonsense mutation to gentamicin treatment.
A comprehensive analysis of the surrounding nucleotides
identified positions playing an important role in determining
readthrough levels and gentamicin response. In particular, we
demonstrated that the nucleotide immediately upstream from the
stop codon was a major determinant of gentamicin response and
that this effect was mediated by the nucleotide itself, rather than
by the nature of the last amino acid or the tRNA present in the
ribosomal P-site.
Based on these findings, we have developed the first rules for
predicting the sensitivity of nonsense mutations to aminoglycoside
treatments based on the surrounding nucleotide sequence.
Results/Discussion
Readthrough quantification for 66 sequences containing
a stop codon
Weanalyzed readthroughlevelsfor66stop codons,includingone
natural termination codon and 65 nonsense mutations implicated in
various diseases (Figure 1 and Table S1): The CFTR gene for cystic
fibrosis [19], the dystrophin gene for Duchenne muscular dystrophy
[3], the LAMA-2 gene for congenital muscular dystrophy [16], the
beta-globin gene for beta-thalassemia (sequences provided by
Jacques Rochette, INSERM U 925-UPJV, Amiens) and the p53
and APC (adenomatous polyposis coli) genes for cancers [20,21].
The stop codon present in the mouse mdx gene is denoted ‘‘MDX’’.
‘‘STOP LAM’’ is the natural termination codon of laminin and
‘‘STOP PLATI’’ is the mouse platinum coat color mutation.
Nonsense mutations are named according to the position of the
modified amino acid in the protein sequence.
For each sequence, the stop codon and the surrounding
nucleotide context, shown in Table S1, were inserted into the
dual reporter vector pAC99 [22]. Readthrough levels were
quantified in NIH3T3 cells transiently transfected with the dual
reporter vector, in the presence or absence of gentamicin. Some of
these nonsense mutations have already been tested in previous
studies in our laboratory. However, as variability is commonly
observed between batches of gentamicin [23], we test all 66 stop
sequences with the same gentamicin preparation (see Materials
and Methods).
Readthrough rates ranged from 0.01% (DMD 2726, beta 43,
APC 1131) to 0.52% (CF 122) for basal readthrough (B), and from
0.04% (p53 327) to 2.79% (p53 213) in the presence of 800 mg/ml
gentamicin (G) (Figure 1, Table S1). The gentamicin response is
defined as the factor of increase (I) between basal and gentamicin-
induced readthrough levels. This factor of increase varied from 1.6
(DMD 2125) to 16.3 (APC 1131). Considerable variability for the
three variables was observed, as previously described. We
characterized readthrough levels and the gentamicin response in
mammalian cells in more detail, by carrying out statistical analysis.
Descriptive statistics for basal and gentamicin-induced
readthrough levels and for the gentamicin response
We studied the distribution and characteristics of the variables
B, G and I, by descriptive statistical analysis (Table S2). For B, the
mean was 0.07% and the median was 0.04%; for G, the mean was
0.37% and the median was 0.23%; for I, the mean was 6.04 and
the median was 5.46. The difference between the mean and the
median indicates asymmetry in the distribution.
We also carried out a graphical analysis to visualize the
distribution of each variable (Figure 2). The variables B and G had
a very high kurtosis (flattening coefficient; 11.11 and 12.71,
respectively), indicating a sharper peak than for a Gaussian
distribution (kurtosis=0). The asymmetry coefficient was 3.22 for
variable B and 3.23 for G, respectively, indicating a strongly
asymmetric and L-shaped distribution, with a high proportion of
low values. The values were found to be homogeneously
distributed, with most located in the first two intervals (Figure 2):
– For basal readthrough (variable B), 83.3% of nonsense
mutations displayed readthrough levels of no more than
Author Summary
Nonsense mutations are single-nucleotide variations
within the coding sequence of a gene that result in a
premature termination codon. The presence of such
mutations leads to the synthesis of a truncated protein
unable to fulfill its normal function. Over the last ten
years, treatment strategies have emerged based on the
use of molecules, such as aminoglycoside antibiotics
(gentamicin) that facilitate the readthrough of premature
termination codons, thus restoring the synthesis of a full-
length protein. Such strategies have been tested for
various genetic diseases, including Duchenne muscular
dystrophy and cystic fibrosis. The readthrough level
depends on the nature of the stop codon and the
surrounding nucleotide context, but little was known of
the rules governing readthrough level and response to
aminoglycosides. In this study, we use a large set of
nonsense mutations for an in-depth statistical analysis
designed to decipher the element of the nucleotide
context responsible for modulating readthrough levels.
We analyse the impact of the six nucleotides upstream
and downstream from the stop codon. We demonstrate
that the presence of a uracil residue immediately
upstream the stop codon is associated with a stronger
response to gentamicin treatment than the presence of
any of the other three nucleotides.
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mutations promoted efficient termination. Readthrough rates
above 0.10% accounted for 16.7% of all values and were
defined as high basal readthrough levels (see Materials and
Methods).
– For gentamicin-induced readthrough (variable G), 80.3% of
nonsense mutations displayed readthrough rates no higher
than 0.5%. Therefore, even in the presence of gentamicin, very
few nucleotide contexts promoted ‘‘high’’ levels of read-
through. Readthrough rates above 0.50% accounted for
19.7% of all values and were defined as ‘‘high’’ levels of
induced readthrough.
For increase factor (variable I), we observed a kurtosis slightly
higher (1.63) than expected for a Gaussian distribution. Its
asymmetry coefficient (1.17) was similar to that for a Gaussian
distribution (=1). The values were homogeneously distributed and
78% of the values had ranks between 4 and 8. Values greater than
8 accounted for 19.7% of all values and were defined as a ‘‘high’’
factor of increase.
We then investigated whether these three distributions could be
converted to Gaussian distributions using the Box-Cox transfor-
mation (l=20.217) (see Materials and Methods), which would
make it possible to use more powerful parametric statistics. After
transformation, a Shapiro-Wilk test allowed us to conclude that B,
G and I variables indeed followed a normal distribution (Figure
S1, Table S3).
Correlation among basal readthrough, induced
readthrough, and gentamicin response
Previous observations have suggested that there is no correlation
between the basal readthrough level for a nonsense mutation and
its sensitivity to gentamicin treatment [3]. However, the sets of
mutations analyzed to date have been too small to demonstrate
this point statistically. We plotted the level of gentamicin-induced
readthrough against basal readthrough and the increase factor
against basal readthrough or against gentamicin-induced read-
through before (Figure S2) and after Box-Cox transformation
(Figure 3). We used the parametric Bravais-Pearson correlation
test to establish the statistical significance of these correlations
(Table S4). There was a strong positive correlation between basal
readthrough level and gentamicin-induced readthrough level
(R=0.845) and this correlation was significant (p,0.0001). There
was a weak negative correlation between basal readthrough and
the factor of increase (R=20.29, p=0.016), indicative of a trend,
with nonsense mutations with a ‘‘high’’ basal readthrough level
tending to be less responsive to gentamicin treatment. There was a
weak positive correlation between gentamicin-induced read-
Figure 1. Readthrough levels and factor of increase for 66 sequences containing a stop codon. Readthrough efficiencies of 66 sequences
(65 nonsense mutations and 1 natural stop codon) were measured in NIH3T3 cells with and without gentamicin (800 mg/ml) treatment for 24 H. Each
value shown is the mean of at least three independent experiments. For each sequence, the factor of increase (I) is the ratio of the gentamicin-
induced readthrough level (G) to the basal readthrough level (B). Sequences are ranked in descending order of gentamicin-induced readthrough
level.
doi:10.1371/journal.pgen.1002608.g001
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nonsense mutations with ‘high’’ gentamicin-induced readthrough
levels also tended to have the highest factor of increase.
These results provide the first description of the relationship
between basal readthrough, gentamicin-induced readthrough and
gentamicin response. They indicate that nonsense mutations with
a ‘‘high’’ basal readthrough level give ‘‘high’’ levels of gentamicin-
induced readthrough. However, some nonsense mutations with a
‘‘low’’ basal readthrough level presented a ‘‘high’’ gentamicin-
induced readthrough level, because they had high factors of
increase. Thus, nonsense mutations were found to behave in
different ways and could be classified into three distinct groups
(Table S1):
Response-type 1: High basal readthrough levels and high
gentamicin-induced readthrough levels (for example, p53 213, CF
122 or DMD931). These nonsense mutations did not have a
particularly high factor of increase.
Response-type 2: A low or medium basal readthrough level
associated with high factor of increase, resulting in essentially high
levels of gentamicin-induced readthrough (for example, APC 1114
or p53 192).
Response-type 3: A low or medium basal readthrough level and
a weak or moderate gentamicin response. Most of the nonsense
mutations studied was of this type.
The first two groups include mutations for which gentamicin
treatment can promote high levels of readthrough. For these
mutations, we would expect to observe clinical benefit for the
treatment, with gentamicin, of diseases linked to the presence of a
nonsense mutation. Indeed, similar levels of induced readthrough
have already been shown to improve the clinical status of cystic
fibrosis patients with CFTR mutations treated with gentamicin
[19].
We hypothesized that the differences in the behavior of these
nonsense mutations should depend on the nature of the stop codon
and the nucleotide context. We therefore assessed the contribution
of each of these factors.
Effect of the type of stop codon
The statistical approach used is described in the Materials and
Methods section and in Figure 4. These 66 sequences were
assigned to three different groups, according to the nature of the
stop codon. There were 14 UAA, 25 UAG and 27 UGA stop
codons. The medians of the three variables are shown, for each
group, in Figure 5.
Figure 2. Graphical representations of the distribution of values for the parameters B, G, and I. For each parameter, values are classified
into intervals of equal size. X-values indicate the limits for intervals. Y-values indicate the number of values in each interval.
doi:10.1371/journal.pgen.1002608.g002
Figure 3. Graphic representations of correlation between the
variables B, G, and I after Box-Cox transformation. Gentamicin-
induced readthrough level is plotted against basal readthrough level
(A); the factor of increase is plotted against basal readthrough level (B)
and against gentamicin-induced readthrough level (C). Bravais-Pearson
tests were performed to analyze the correlations between the three
variables after Box-Cox transformation. Statistically significant results
are indicated in Table S4.
doi:10.1371/journal.pgen.1002608.g003
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normal distribution for these 3 variables, an ANOVA test revealed
that the three groups differed significantly in terms of their basal
and induced readthrough levels. A LSD test yielded the following
hierarchy: UGA.UAG.UAA (the sign.represents a statistical
difference) for both basal and induced readthrough levels (Table 1
and Table S5). This hierarchy is consistent with previous reports
but, to our knowledge, this study provides the first evidence of a
statistically significant difference between stop codons. However,
some UAA codons have higher readthrough levels than some
UGA or UAG codons (i.e. CF 122), highlighting the crucial role of
nucleotide context in determining readthrough level in the
presence or absence of gentamicin.
Conversely, ANOVA test revealed that the factor of increase
did not differ significantly between the three groups (Table S5).
We show here that the factor of increase, which reflects the
capacity of a nonsense mutation to respond to treatment, was
independent of the nature of the stop codon. The factor of increase
therefore probably depends only on the nucleotide context of a
given nonsense mutation.
Effects of nucleotide context
We then investigated the effects of nucleotide context, by the
same statistical approach used for investigation of the effects of
stop codon identity (see Materials and Methods and Figure 4). Six
Figure 4. Statistical approach. Description of the statistical
approach used for the study of the impact of identity of the stop
codon or nucleotide context on readthrough levels and response to
gentamicin.
doi:10.1371/journal.pgen.1002608.g004
Figure 5. Effect of stop codon identity on readthrough levels
and the factor of increase. Graphical representation of medians
(before Box-Cox transformation) for the parameters B, G and I are
shown for the three different stop codons: UAA, UAG and UGA. The
results of the statistical analysis after Box-Cox transformation are shown
in Table S5. For basal and gentamicin-induced readthrough levels, the
following hierarchy of readthrough level was established: UGA.UA-
G.UAA. (with.indicating a significant difference). For the factor of
increase, UGA=UAG=UAA.
doi:10.1371/journal.pgen.1002608.g005
Table 1. Effects of the nucleotide context and the stop codon
on basal readthrough (B), gentamicin-induced readthrough
(G) and increase factor (I).
BGI
26 C.U- A.U/ U .G
25 /A , C .G/
24 ///
23 //A, C, U.G
*
22 //C .A





+4 C.A, G, U C.A, G, U
* C.U






Hierarchies were established based on ANOVA/LSD tests after normalization of
B, G and I. The sign.indicates a higher level of readthrough or factor of
increase. In bold results obtained with a p#0.05 (Table S5 and Table S6).
*p#0.005.
doi:10.1371/journal.pgen.1002608.t001
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already been shown to influence readthrough level in eukaryotes
[6]. We therefore analyzed the effect of each nucleotide in this
interval. Graphic representations of the medians of B, G and I
(before normalization of the data), for each nucleotide, at each
position (from 26t o+9), were generated (Figure 6).
After Box-Cox transformation we were able to use parametric
statistical tests (ANOVA and LSD) to define a hierarchy for some
positions (Table 1). Bartlett p value and ANOVA F and p-values
are indicated in Table S6, Table S7 and Table S8. These analyses
were conducted with the complete data set, but could not be
applied to each class of stop codon separately, because the number
of mutations in each class was too small for statistical analysis. Our
analysis thus only identified determinants valid for all three types
of stop codon.
We first compared the effect of each nucleotide at a given
position to the three others at the same position (Table S6). Our
findings confirmed the involvement of distal 59 and 39 determi-
nants of nucleotide sequence context in the control of readthrough
level and gentamicin response. Indeed, for the nucleotides in
positions 26t o+9, we were able to establish correlations between
particular classified bases and high levels of readthrough or strong
gentamicin response. Nucleotides can be classified according to
their effect, for at least one variable, for nine (26, 25, 23, 22,
21, +4, +5, +8, +9) of the twelve positions studied. For example,
an adenine or a cytosine residue in position 26 was associated
with higher basal readthrough levels than observed for a uracil
residue. A guanine residue in position +8 was associated with a
stronger gentamicin-induced readthrough than a cytosine residue
in this position. The presence of a uracil residue in position +9 was
associated with a stronger gentamicin response than a cytosine or a
guanosine residue in this position (Table 1).
These findings contrast with results previously obtained in yeast,
which pointed out the role of the two adenine residues
immediately upstream from the stop codon in the absence of
treatment [8]. This discrepancy is possibly due to differences
between mammals and yeast, or to the use of a sequence harboring
a motif downstream from the stop codon responsible for
promoting particularly high levels of readthrough in this previous
study.
Two major determinants were identified in this study (Table 1):
– The +4 position, at which a cytosine residue is correlated with
higher basal (p=0.06) and gentamicin-induced readthrough
(p=0.001) than the tree other nucleotides. A C residue in this
position has been shown to promote high levels of readthrough
in both yeast and mammalian cells, but only in a small number
of nucleotide contexts [4,24]. This statistical analysis demon-
strates that this effect operates for a large set of sequences.
– The 21 position, at which a uracil residue is associated with
higher levels of gentamicin-induced readthrough level
(p=0.02) and a stronger gentamicin response (p,0.005) than
for other nucleotides. This is the first time that the presence of a
nucleotide at a specific position has been linked to a better
response to gentamicin treatment.
However among mutation presenting a U in 21 position, 30%
also present a C in +4 (against 8% for mutation with an A, 12% for
mutation with a G and 29% for mutation with a C in 21). To
assess that the effect of U in 21 is not biased by the presence of a
Ci n+4, we performed the same statistical analysis restricting the
pool of mutations to those without a C in +4. In this subset, the
mean value of gentamicin-induced readthrough and increase
factor is even better when there is a U in 21 position compared to
the 3 other nucleotides (Table S7). This result confirms the effect
of a uracil in 21 position independently of the presence of a C in
+4. Nevertheless, according to the statistical test performed, it can
be noticed that for induced-readthrough level there is a combined
effect between the U in 21 position with a C in +4 position.
Indeed, all the nonsense mutations studied that carried a U Stop C
sequence systematically displayed readthrough levels exceeding
0.5% in the presence of gentamicin.
We checked that the determinants identified here were
retrospectively consistent with published readthrough analyses.
Keeling and Bedwell [5] measured the levels of readthrough
induced by several aminoglycosides in a mammalian translation
system. The mutation displaying the highest levels of gentamicin-
and amikacin-induced readthrough was indeed the only one with a
‘‘U stop C’’ sequence. The combination of these two nucleotides
on either side of the stop codon therefore constitutes the first rule
ever elucidated for identifying patients with nonsense mutations
likely to respond to aminoglycoside treatment.
We also compared the effect of each nucleotide at a given
position to the four nucleotides at all positions on B, G and I. This
procedure reveal a clear effect for the increase factor p=0.0002
(Table S8). For example a uracil residue in position 21 was
associated with higher increase factor than observed for a
guanosine residue in position 23.
Experimental validation of the effect of the nucleotide in
position 21
We analyzed the effect of the nucleotide in position 21
independently of the influence of other nucleotides, by quantifying
the readthrough levels of six nonsense mutations in which we
changed only the nucleotide in position 21, keeping the rest of the
sequence constant:
– DMD 673 (UAG, response-type 1) and DMD 319 (UGA,
response-type 1) have a U residue in position 21, which we
replaced with each of the other three nucleotides (A, C, G)
separately.
– CF 122 (UAA, response-type 1), DMD 931 (UAG, response-
type 1), beta 17 (UAG, response-type 3) and p53 146 (UGA,
response-type 3) have a G, A, C or G residue, respectively, in
position 21. We replaced each of these residues by a U residue.
Readthrough levels were quantified in NIH3T3 cells in the
presence or absence of gentamicin (Figure 7), statistical data and
standard error of the mean are indicated in Table S9. We found
that the presence of a U residue in the 21 position was
systematically associated with a higher factor of increase than
the presence of any other nucleotide in this position. This result
confirms the statistical analysis of the 66 nonsense mutations.
However, for this narrow panel of stop contexts, gentamicin-
induced readthrough levels were not necessarily higher in the
presence of a U residue. These levels could be lower (DMD 673,
p53 146 and CF 122), equivalent (DMD 931) or higher (DMD
319, beta 17). The effect of the nucleotide in position 21o n
gentamicin-induced readthrough level therefore depends strongly
on the nature of the other nucleotides surrounding the stop codon.
These results provide evidence that the nucleotide immediately
upstream from the stop codon is a major determinant of
gentamicin response, with an uracil residue in this position
associated with stronger responses to gentamicin treatment. For
therapeutic purpose, readthrough levels in presence of gentamicin
are the relevant variable. However, the capacity of a nonsense
mutation to increase its readthrough level after antibiotic
treatment could be a crucial point in the future as new
Statistical Analysis of Readthrough Levels
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currently developing news molecules derived from aminoglyco-
sides and acting in a similar way but with a greater efficiency [25–
27]. In this case, a nonsense mutation with a good increase factor
could overtake the threshold of 0.5% of readthrough.
We then examined how the nucleotide upstream from the stop
codon exerted its effect on readthrough levels. In prokaryotes, the
chemical properties of the ultimate amino acid in the nascent
polypeptide chain have been reported to modulate translational
readthrough [28,29]. The 21 nucleotide may also influence
readthrough by interacting directly with the P site tRNA or indirectly
with eRF1. We therefore investigated whether the final tRNA or
amino acid incorporated had an effect on readthrough levels.
The nature of the last amino acid has no effect on
readthrough levels
The nucleotide in the 21 position is the third base of the codon
immediately upstream from the stop codon (codon 21). During
translation termination, the stop codon is located in the ribosomal
A-site and codon 21 is in the P-site. We therefore investigated
whether having a hydrophilic or hydrophobic amino acid at the P
site was correlated with higher levels of readthrough or stronger
gentamicin responses. A two-tailed t-test comparing the two
groups (hydrophobic or hydrophilic amino acid) for all the
nonsense mutations studied showed that there is no relationship
between the nature of the final amino acid and a high factor of
increase (t=20.91; p=0.36) or high readthrough rates (t=1.71;
p=0.09 for B and t=1.28; p=0.2 for G). Moreover, the amino
acids encoded by codons ending in U do not belong to a particular
chemical class.
These results strongly suggest that the nature of the amino acid at
the ribosomal P-site is not a major determinant of readthrough levels.
The identity of the tRNA at the P site has no effect on
readthrough levels
We then investigated whether the effect of the nucleotide in the
21 position on the factor of increase was due to the nature of the
tRNA at the P site. Nucleotides 1, 2 and 3 of the mRNA codon are
recognized by nucleotides 36, 35 and 34, respectively of the tRNA
anticodon (Figure S3A). Codons ending in a C or U residue may
be recognized through wobble pairing at position 34 of the
anticodon (Figure S3B). In such situations, a single tRNA may
recognize several codons. There are two possibilities in eukaryotes:
nucleotides U3 and C3 of the codon may be recognized by
nucleotides A34 or G34 on the anticodon. Thus, U3 may be
recognized by wobble pairing (G34) or Watson-Crick pairing
(A34). We investigated the way in which recognition of the codon
in position 21 affected readthrough levels or gentamicin response,
by comparing nonsense mutations for which the 21 codon is
recognized by wobble pairing with those recognized by Watson-
Crick pairing, in two-tailed t-test. We found no significant
difference between these two types of nonsense mutation, for B
(t=0.61; p=0.54), G (t=0.63; p=0.53) or I (t=20.099;
p=0.92). The strength of base pairing between the 21 codon
and the corresponding anticodon therefore seems to have no
influence on readthrough levels or gentamicin response.
We investigated whether the effect of the 21 nucleotide on the
factor of increase was correlated with the identity of the tRNA,
using four nonsense mutations: beta 17, DMD 319, (Figure 7) and
APC 1131 (UAA, response-type 2), APC 1114 (UGA, response-
type 2) (Figure 8). The third base of the 21 codon of these
nonsense mutations was changed to create an alternative –1 codon
recognized by the same tRNA (Table 2). For example, the AAU
21 codon of the APC 1114 nonsense mutation was replaced by an
AAC codon, which is also recognized by the (39R59) UUG
anticodon of the same tRNA ASN. Readthrough levels were
quantified in NIH3T3 cells transiently transfected with the dual
reporter vector containing the appropriate sequence, in the
presence or absence of gentamicin. For these nonsense mutations,
the factor of increase and the gentamicin-induced readthrough
were higher when there was a U residue in position 21 than when
there was another base in this position, while the modified codon
was recognized by the same tRNA. These findings provide strong
evidence for a lack of involvement of the tRNA at the ribosomal P-
site in determining the gentamicin response.
Thus, the nucleotide in the 21 position is itself a major
determinant of the gentamicin response and of the gentamicin-
induced readthrough level.
Conclusion
We used the largest set of nonsense mutations ever analyzed for
the first statistical analysis of the influence of nucleotide context on
PTC readthrough and response to aminoglycoside treatment. We
confirm the findings of previous studies concerning the importance
of the nucleotide in the +4 position, at which the presence of a
cytosine (C) residue is correlated with high basal and gentamicin-
induced readthrough levels. We also show for the first time that the
presence of a U residue in 21 is a key determinant of gentamicin-
induced readthrough which is the relevant parameter for clinical
applications. Moreover, we can notice that a U in 21 is also
correlated with a higher increase factor between basal and
gentamicin-induced readthrough. This finding may have impor-
tant implications in fundamental aspects of structural interactions
between readthrough inducers and the translational apparatus.
We show that impact of the base in the 21 position is mediated
neither by the last amino acid nor by the tRNA present at the
ribosomal P site.
These data are consistent with previous reports excluding a role
for the last residue of the polypeptide chain or the last
incorporated tRNA in readthrough efficiency in eukaryotes
[8,30]. Different rules seem to apply in prokaryotes, as the two
last amino acids and the tRNA present in the P site have been
shown to influence termination efficiency in E. coli [31]. It remains
unclear how this nucleotide modulates the factor of increase in
mammals. One possible hypothesis is that the stacking properties
of this base in the vicinity of the stop codon are involved in the
balance between translation termination and suppression. More
generally, this nucleotide, which is close to the decoding center
targeted by aminoglycosides, may induce local structural rear-
rangements favoring the influence of aminoglycosides at the
ribosomal A site.
Finally, the consensus sequence U STOP C was systematically
associated with induced readthrough levels greater than 0.5%.
The combination of these two nucleotides before and after the stop
codon may therefore provide an initial indicator of readthrough
levels compatible with therapeutic benefit.
Figure 6. Effect of nucleotide identity at each position (26t o+9) on readthrough levels and the factor of increase. Graphical
representations of medians for the parameters B, G and I (before Box-Cox transformation) for the four different nucleotides (A, C, G or U) at each
position in the sequence surrounding the codon stop (26t o+9). Statistical analysis was performed after Box-Cox transformation and results are
summarized in Table 1 and detailed in Table S6.
doi:10.1371/journal.pgen.1002608.g006
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Cell lines and cell culture
NIH3T3 cells (embryonic mouse fibroblasts kindly provided by
MarcSitbon) were culturedinDMEMplus GlutaMAX(Invitrogen).
The medium was supplemented with 10% foetal calf serum (FCS,
Invitrogen) and 100 U/ml penicillin/streptomycin. Cells were kept
in a humidified atmosphere containing 5.5% CO2 at 37uC.
Readthrough quantification in cell culture
Complementary oligonucleotides corresponding to nonsense
mutations embedded in their natural context (sequences in Table
Figure 7. Effect of the nucleotide upstream from the stop codon (21) on readthrough levels and response to gentamicin. For DMD
319 and DMD 673, a U residue immediately upstream from the stop codon (21) was replaced by each of the other nucleotides, separately. For DMD
931, p53 146, beta 17 and CF 122, the original nucleotide in the 21 position was replaced by a U residue. Readthrough efficiencies were measured as
described in Figure 1. Each value shown is the mean of at least five independent experiments. The original nucleotide is underlined on each graph.
doi:10.1371/journal.pgen.1002608.g007
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plasmid, as previously described [22]. This dual reporter can be
used to quantify stop-codon readthrough, through the measure-
ment of luciferase and beta-galactosidase (internal calibration)
activities, as previously described [19]. Readthrough levels for
nonsense mutations were analyzed in the presence or absence of
gentamicin. All nonsense mutations were tested with batches of
gentamicin with identical efficiency of readthrough levels. For p53
and APC, results were obtained from recent studies [20,21]. For
CF, DMD and CMD [19], [3] and [16], readthrough levels had
already been estimated but the tests were repeated in this study, to
prevent discrepancies due to the use of different batches of
gentamicin. NIH3T3 cells were electroporated with 20 mgo f
reporter plasmid. The following day, the cells were rinsed and
fresh medium, with or without gentamicin (800 mg/ml), was
added. No cell toxicity was observed with this dose of antibiotic.
Cells were harvested 24 hours later, by trypsin-EDTA treatment
(Invitrogen) and lysed. Beta-galactosidase and luciferase activities
were assayed as previously described [22]. Readthrough efficiency
was estimated by calculating the ratio of luciferase activity to beta-
galactosidase activity obtained with the test construct, normalizing
the value obtained with respect to that obtained with an in-frame
control construct. For each construct, we performed at least three
independent transfection experiments (3 to 10 experiments).
Statistical analysis
Excel was used for statistical analysis: the Analysis Toolpack for
descriptive statistics; the XL- stat for Bartlett correlation tests
(Bravais-Pearson) and t-tests, Analyse-it module for ANOVA and
LSD tests.
Descriptive statistics (Table S2) provided simple information
(mean, median etc.) about three variables: basal readthrough level
(B), gentamicin-induced readthrough level (G) and the factor of
increase between basal and induced readthrough levels (I). The
median, which is obtained by arranging the values in size order
and selecting the middle value, is useful when the distribution does
not follow a Gaussian distribution (i.e. for variables that do not
tend to cluster around a single mean value). Graphical analysis was
performed and the values of each variable were ranked (Figure 2).
The intervals between different ranks were identical and no
minimal number of values per rank was required. The intervals
and number of rows were defined according to a convention
Figure 8. The nature of the tRNA at the P site is not the major determinant of the gentamicin response. The APC 1114 and APC 1131
nonsense mutations originally had a U residue in the 21 position, which we replaced with a C residue. For each sequence, the two different codons
at the P-site are recognized by the same tRNA (Table 2). Readthrough efficiencies were measured as described in Figure 1. Each value shown is the
mean of at least five independent experiments. The original nucleotide is underlined on each graph.
doi:10.1371/journal.pgen.1002608.g008
Table 2. Codon and anticodon immediately upstream of the stop codon (21 position).
Nonsense mutations Beta 17 DMD 319 APC 1114 APC 1131
Stop codon UAG UGA UGA UAA
Nucleotide in 21 CUCUC UCU
Last Amino-acid GLY GLY PRO PRO ASN ASN CYS CYS
Codon (59R39)i n21 GGC GGU CCC CCU AAC AAU UGC UGU
Anticodon (39R59) CCG CCG GGA GGA UUG UUG ACG ACG
Codons at 21 of these sequences are recognized by the same tRNA. In bold, the original nucleotide at 21 position and the Wobble pairing.
doi:10.1371/journal.pgen.1002608.t002
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and maximal values for each of the variables studied. Values
included in ranks corresponding to the best ,20% of values were
defined as ‘‘high’’.
Several parameters (Kurtosis coefficient, asymmetry coefficient
etc.) and graphical analysis were used to determine whether the
distribution of each variable followed a Gaussian distribution. A
Gaussian distribution is characterized by a Kurtosis coefficient of 0
and an asymmetry coefficient of 1.
In order to perform a complete statistical analysis we chose to
use parametric tests instead of low-power non-parametric analysis.
To this aim, we performed a Box-Cox transformation for variables
B, G and I with Yl(x)=(x
l21)/l using the same lambda: 20.217.
After this transformation, a Shapiro-Wilk test allowed us to
conclude that B, G and I follow a normal distribution.
Correlations between variables were analyzed with the
parametric Bravais-Pearson test. The null hypothesis (H0) was
‘‘there is no correlation between the two variables studied (R=0).
The alternative hypothesis (H1) was ‘‘there is a correlation between
the two variables studied (R?0)’’. A perfect positive correlation
gives an R value of +1, whereas a perfect negative correlation gives
an R value of 21. The significance level was set at 0.05.
In order to analyze the effect of the nature of the stop codon or
the nucleotide context on readthrough levels and gentamicin
response the 66 stop codons were divided into three groups for
stop codon studies (UAA, UAG and UGA) and four groups for
nucleotide context studies (U, C, A, G). For each group, we then
used a Bartlett test to analyze heterogeneity of variance of each
variable. If heterogeneity was not significant we performed one of
the most commonly used multiple comparison procedure, the
Fisher’s Least Significant Difference (LSD) test. The LSD test is a
two-step test. First an ANOVA (Analysis Of Variance) test is
performed. The null hypothesis for ANOVA is that the mean
(average value of the dependent variable) is the same for all groups.
The alternative hypothesis is that the mean is not the same for all
groups. When the null hypothesis is rejected, it means that at least
2 groups are different from each other. In a second step we
determine which groups are different from which performing all
pairwise t-tests. This last procedure allows to establish a hierarchy
between stop or nucleotide at each position. In Table S6 each
nucleotide at a given position is compared to the others at the
same position and in Table S8 each nucleotide is compared to the
four nucleotides at all position.
Two-tailed Student’s t-tests (excel) were used to study the
influence of tRNA or the amino acid in the ribosomal P-site. For
this test, we used a significance level a of 0.05.
Supporting Information
Figure S1 Plots representing normal distribution of B, G and I
after Box-Cox transformation using a common lambda=20.217.
(TIF)
Figure S2 Graphic representations of correlation between the
variables B, G and I before Box-Cox transformation. Gentamicin-
induced readthrough level is plotted against basal readthrough
level (A); the factor of increase is plotted against basal readthrough
level (B) and against gentamicin-induced readthrough level (C).
For each graph, the trend curve is shown.
(TIF)
Figure S3 Codon-anticodon recognition rules. A. The nucleo-
tides in positions 1, 2 and 3 of the codon are recognized by the
nucleotides in positions 36, 35 and 34, respectively, of the tRNA
anticodon. B. In eukaryotes, the nucleotide in position 34 of the
anticodon can recognize two different nucleotides in position 3 of
the codon. A, U or a C residue in position 3 of the codon may be
recognized by an A or a G residue in position 35 of the tRNA.
Thus, some codons are recognized by wobble pairing with the
anticodon.
(TIF)
Table S1 List of the 66 sequences containing a stop codon, with
basal readthrough (B), gentamicin induced readthrough (G),
increase factor between basal and induced readthrough (I) and
the classified group in response-type. These sequences were
inserted into the dual reporter vector in order to determine
readthrough level. Nonsense mutations are named by the gene or
the disease related to and by their position (amino-acid). p53
mutations are involved in cancers; DMD and CMD mutations are
involved in muscular dystrophies; CF mutations are involved in
cystic fibrosis and beta mutations are involved in beta-thalassemia
disease (see Materials et Methods for references). Nonsense
mutations are classified according to their gentamicin induced
readthrough level.
(PDF)
Table S2 Descriptive statistics for the 3 parameters B, G and I
before Box-Cox transformation.
(PDF)
Table S3 Shapiro Test after Box-Cox transformation
(l=20.217).
(PDF)
Table S4 Bravais-Pearson statistical analysis of correlation
between basal readthrough, induced readthrough and gentamicin
response (Increase Factor) after Box-Cox transformation.
(PDF)
Table S5 Statistical analysis of the effect of the type of stop
codon on B, G and I after Box-Cox transformation using a
common lambda: 20.217 (this transformation leads to negative
value for B and G).
(PDF)
Table S6 Statistical analysis of the effect of each nucleotide at
each position on B, G and I after Box-Cox transformation using a
common lambda: 20.217 (this transformation leads to negative
value for B and G).
(DOC)
Table S7 Statistical analysis of the effect of nucleotide in 21
position on B, G and I (after Box-Cox transformation) restricting
the pool of mutations to those without a C in +4.
(DOC)
Table S8 Statistical analysis of the effect of all nucleotides on B,
G and I after Box-Cox transformation using a common lambda:
20.217. The significant differences between each nucleotide
against all nucleotides at all positions are listed. In this list, inc is
for Increase Factor A, G, C or U for the nucleotide and the 2 or +
followed by a number for position.
(DOC)
Table S9 Statistical data (Standard deviation and standard error
of the mean) of studied nonsense mutations (Figure 7 and Figure 8).
(DOC)
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